In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007

In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007–2009 study

Published:2011-03 Issue:3 Volume:69 Page:348-355
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Walkty Andrew,Adam Heather J.,Laverdière Michel,Karlowsky James A.,Hoban Daryl J.,Zhanel George G.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference34 articles.

1. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin;Bogdanovich;Antimicrob. Agents Chemother.,2005

2. Epidemiology of methicillin-resistant Staphylococcus aureus;Boucher;Clin. Infect. Dis.,2008

3. Ceftobiprole: farewell or just a delay?;Chahine;Am J Health-Syst Pharm,2010

4. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—7th ed. M7-A7;Clinical and Laboratory Standards Institute (CLSI),2006

5. Performance standards for antimicrobial susceptibility testing, 20th informational supplement. M100-S20;Clinical and Laboratory Standards Institute (CLSI),2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftobiprole medocaril for the treatment of pneumonia;Expert Review of Anti-infective Therapy;2023-04-18

2. New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA);Antibiotics;2023-04-12

3. Ceftobiprole activity against Gram-positive and Gram-negative pathogens causing bone and joint infections in the United States from 2016 to 2020;Diagnostic Microbiology and Infectious Disease;2022-07

4. Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management;Microorganisms;2021-03-05

5. New cephalosporins for the treatment of pneumonia in internal medicine wards;Journal of Thoracic Disease;2020-07